Metabolic Syndrome X  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00443755: Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

Completed
2
28
US
metformin, Fortamet, Glucophage, Glucophage Extended Release (XR), Glumetza, Riomet, pioglitazone, Actos, Placebo
Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Takeda Pharmaceuticals North America, Inc., National Center for Research Resources (NCRR)
Type 2 Diabetes, Insulin Resistance, Metabolic Syndrome
08/10
08/10
NCT00671515: Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome

Completed
2
23
US
Pioglitazone, Actos
Joseph Calabrese, MD, Takeda Pharmaceuticals North America, Inc.
Depressive Disorder, Major, Metabolic Syndrome X
08/11
11/11
POEM, NCT00736996: Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)

Completed
2
78
US
Pioglitazone, Actos, Placebo, Endurance Exercise Training
University of Colorado, Denver, National Institute on Aging (NIA)
Mild Cognitive Impairment
12/13
12/13

Download Options